Valuation: Bio-Rad Laboratories, Inc.

Market Cap 9.41B 8.12B 7.64B 6.95B 13.07B 901B 13.26B 89.66B 35.14B 451B 35.31B 34.55B 1,501B P/E 2026 *
42.6x
P/E 2027 * 41.7x
Enterprise Value 8.66B 7.48B 7.03B 6.39B 12.03B 829B 12.2B 82.52B 32.34B 415B 32.5B 31.8B 1,382B EV / Sales 2026 *
3.36x
EV / Sales 2027 * 3.21x
Free-Float
60.2%
Yield 2026 *
-
Yield 2027 * -
1 day-0.55%
1 week-0.79%
Current month+8.59%
1 month+17.07%
3 months+25.41%
6 months+30.58%
Current year+16.65%
1 week 351
Extreme 351
365
1 month 285.39
Extreme 285.39
365
Current year 236.73
Extreme 236.73
365
1 year 236.73
Extreme 236.73
365
3 years 211.43
Extreme 211.43
406.44
5 years 211.43
Extreme 211.43
832.7
10 years 147.68
Extreme 147.68
832.7
Manager TitleAgeSince
Chief Executive Officer 76 01/01/2003
President 61 09/09/2024
Director of Finance/CFO 55 15/04/2024
Director TitleAgeSince
Chairman 76 01/01/2012
Director/Board Member 73 25/04/2017
Director/Board Member 79 25/04/2017
Date Insider Type Main position Quantity % Market Cap.
25/7/26 Fiscal year

Executive/Senior Manager

581 0.0027%
24/4/26 Fiscal year

Chief Financial Officer

2,576 0.0117%
6/11/25 Sell

EVP, President, LSG

700 0.0032%
Change 5-day change 1-year change 3-year change Capi.($)
-0.55%-0.79%+24.16%-7.10% 9.41B
+2.29%+2.90%-13.33%+8.87% 191B
+2.26%+2.12%-0.22%+13.60% 116B
+2.34%-4.46%+9.86%+76.82% 59.64B
-0.42%+0.15%+35.69%+70.27% 55.42B
+0.43%+0.57%-6.44%-33.34% 49.6B
+2.01%+0.97%+11.85%-14.76% 33.49B
-0.19%-0.98% - - 30.6B
-1.60%+0.10%-6.25%+25.51% 24.25B
-0.11%-1.49%+42.39%-10.74% 24.39B
Average +0.63%+0.58%+10.86%+14.35% 59.38B
Weighted average by Cap. +1.41%+0.80%+2.10%+17.56%

Financials

2026 *2027 *
Net sales 2.57B 2.22B 2.09B 1.9B 3.57B 247B 3.63B 24.53B 9.61B 123B 9.66B 9.45B 411B 2.63B 2.27B 2.14B 1.95B 3.66B 252B 3.71B 25.1B 9.84B 126B 9.89B 9.67B 420B
Net income 225M 194M 183M 166M 313M 21.56B 317M 2.14B 841M 10.78B 845M 826M 35.91B 230M 199M 187M 170M 320M 22.04B 324M 2.19B 859M 11.02B 864M 845M 36.71B
Net Debt -749M -647M -609M -553M -1.04B -71.77B -1.06B -7.14B -2.8B -35.89B -2.81B -2.75B -120B -965M -834M -785M -713M -1.34B -92.5B -1.36B -9.2B -3.61B -46.26B -3.62B -3.55B -154B
Logo Bio-Rad Laboratories, Inc.
Bio-Rad Laboratories, Inc. is engaged in developing, manufacturing, and marketing a range of products for the life science research and clinical diagnostics markets. The Company offers a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. It operates through two segments: Life Science and Clinical Diagnostics. The Life Science segment develops, manufactures, and markets instruments, systems, reagents, and consumables used for biological research, biopharmaceutical production processes, food testing regimes, and science education. Its Clinical Diagnostics segment designs, manufactures, markets and supports test systems, informatics systems, test kits and specialized quality controls that serve clinical laboratories in the global diagnostics market. These products are sold to hospital laboratories, diagnostic reference laboratories, transfusion laboratories, and physician office laboratories.
Employees
7,450
Date Price Change Volume
19/08/26 USD 353.56 -0.47% 62,647
17/08/26 USD 355.23 -0.29% 213,508
14/08/26 USD 356.26 -1.36% 173,819
13/08/26 USD 361.19 -0.25% 207,470
12/08/26 USD 362.08 +1.64% 233,885
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
5
Last Close Price
355.23USD
Average target price
329.00USD
Spread / Average Target
-7.38%

Quarterly revenue - Rate of surprise